Abstract
Leukocyte recruitment from the vasculature into tissues is a crucial component of the immune system but is also key to inflammatory disease. Chemokines are central to this process but have yet to be therapeutically targeted during inflammation, due to a lack of mechanistic understanding. Specifically, CXCL4 (Platelet Factor 4, PF4) has no established receptor that explains its function. Here we use biophysical, in vitro and in vivo techniques to determine the mechanism underlying CXCL4 mediated leukocyte recruitment. We demonstrate that CXCL4 binds to glycosaminoglycan (GAG) sugars on proteoglycans within the endothelial extracellular matrix resulting in increased adhesion of leukocytes to the vasculature, increased vascular permeability and non-specific recruitment of a range of leukocytes. Furthermore, GAG sulphation confers selectivity onto chemokine localisation. These findings represent a new understanding of chemokine biology, providing novel mechanisms for future therapeutic targeting.
Original language | English |
---|---|
Article number | 111930 |
Journal | Cell Reports |
Volume | 42 |
Issue number | 1 |
Early online date | 5 Jan 2023 |
DOIs | |
Publication status | Published - 31 Jan 2023 |
Keywords
- CXCL4
- PF4
- Chemokine
- Proteoglycan
- Glycosaminoglycan
- Extracellular Matrix
- Leukocyte
- Recruitment
- Trafficking
Research Beacons, Institutes and Platforms
- Manchester Cancer Research Centre